In addition, investigation of how Wnt5a may modulate proteasomal degradation of YAP—including its effects on E3 ligase interactions and ubiquitination—will be necessary to comprehensively delineate the upstream regulation of YAP stability in trastuzumab-resistant cancers. The gene discussed is YAP1; the disease is cancer.